Drugs / inactivated EV71 vaccine
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01391494 | Feb → Jun 2011 | hand, foot and mouth disease | Institute of Medical Biology, Chinese Academy of Medical Sciences | Completed | No outcome recorded |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT01569581 | Mar 2012 → Mar 2013 | — | Institute of Medical Biology, Chinese Academy of Medical Sciences | Completed | Met primary |
| Phase 43 trials | ||||||
| Phase 4 | NCT03240744 | Jun 2017 → Oct 2020 | hand, foot and mouth disease | Chinese Academy of Medical Sciences | Unknown | No outcome recorded |
| Phase 4 | NCT03001986 | Sep 2016 → Dec 2017 | hand, foot and mouth disease | Institute of Medical Biology, Chinese Academy of Medical Sciences | Completed | No outcome recorded |
| Phase 4 | NCT02999828 | Sep 2016 → Feb 2019 | — | Chinese Academy of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | inactivated EV71 vaccine | “The purpose of phase III is to evaluate the safety and efficacy of the formalin-inactivated EV71 vaccine in Chinese infants and children (from 6 to 71 months old) to protect...” NCT01569581 ↗4“a formalin-inactivated EV71 vaccine (Human Diploid cell, KMB-17 Cell) has been licensed by SFDA in China, Dec. 2010.” NCT01391494 ↗ |
| Modality | Vaccine | “a formalin-inactivated EV71 vaccine (Human Diploid cell, KMB-17 Cell) has been licensed by SFDA in China, Dec. 2010.” NCT01391494 ↗ |
| Route | Intramuscular | “Two doses of an inactivated EV71 vaccine or placebo were administered intramuscularly” PMID 24571755 ↗ Feb 2014 |